Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

AI Technology Aims to Improve Skin Cancer Assessment and Reduce Biopsies

Just now October 1, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A new AI-guided light analysis technology has been developed to assess skin cancer more accurately and reduce unnecessary biopsies. This advancement could benefit global health, including in Iran, where skin cancer is a growing concern. The technology aims to improve diagnosis and treatment efficiency.

Skin cancer is the most common cancer in the United States and among the most common worldwide. Nearly 1.5 million new cases were diagnosed globally in 2024, including nearly 340,000 melanomas. Nonmelanoma skin cancers—primarily basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—are even more common, with 5.4 million cases diagnosed annually in the U.S.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →